US Stock MarketDetailed Quotes

GTBP GT Biopharma

Watchlist

2.8441
-0.0359-1.25%

Trading Jul 9 11:13 ET

6.13MMarket Cap-402P/E (TTM)

GT Biopharma Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Quarterly+Annual

YOY

Hide blank lines

(Q1)Mar 31, 2024

(FY)Dec 31, 2023

(Q4)Dec 31, 2023

(Q3)Sep 30, 2023

(Q2)Jun 30, 2023

(Q1)Mar 31, 2023

(FY)Dec 31, 2022

(Q4)Dec 31, 2022

(Q3)Sep 30, 2022

(Q2)Jun 30, 2022

Assets

Current assets

Cash, cash equivalents and short term investments

-50.72%9.81M

-15.36%13.97M

-22.95%16.01M

-24.24%17.97M

-25.58%19.9M

-48.38%16.51M

-41.80%20.78M

-39.94%23.73M

-Cash and cash equivalents

-4.65%1.95M

-80.98%1.08M

7.42%2.65M

-48.36%2.77M

-71.93%2.05M

-36.75%5.67M

-74.54%2.47M

-86.44%5.36M

-Short-term investments

-55.99%7.86M

18.98%12.89M

-27.04%13.37M

-17.21%15.21M

-8.22%17.85M

-52.91%10.84M

-29.63%18.32M

--18.37M

Other current assets

105.26%78K

55.56%84K

-56.82%38K

-78.38%48K

-91.61%38K

-71.58%54K

3.53%88K

258.06%222K

Total current assets

-50.42%9.89M

-15.13%14.06M

-23.09%16.05M

-24.75%18.02M

-26.68%19.94M

-48.52%16.56M

-41.70%20.87M

-39.48%23.95M

Non current assets

Net PPE

-80.71%27K

-67.88%53K

-54.21%87K

-46.73%114K

-40.93%140K

--165K

--190K

--214K

-Gross PPE

-80.71%27K

-67.88%53K

-54.21%87K

-46.73%114K

-40.93%140K

--165K

--190K

--214K

Non current prepaid assets

----

--0

0.00%9K

--9K

Total non current assets

-81.88%27K

-69.54%53K

-51.76%96K

-44.84%123K

-39.43%149K

--174K

--199K

--223K

Total assets

-50.65%9.91M

-15.70%14.11M

-23.36%16.15M

-24.93%18.14M

-26.80%20.09M

-47.97%16.74M

-41.14%21.07M

-38.91%24.17M

Liabilities

Current liabilities

Payables

2.62%3.21M

37.83%4.33M

19.40%3.97M

-51.80%3.5M

-61.41%3.13M

-61.66%3.14M

18.67%3.33M

385.17%7.26M

-accounts payable

2.62%3.21M

37.83%4.33M

19.40%3.97M

-51.80%3.5M

-61.41%3.13M

-61.66%3.14M

18.67%3.33M

385.17%7.26M

Current accrued expenses

16.16%963K

-28.40%1.2M

-33.12%1.03M

8.24%1.22M

-29.15%829K

-12.20%1.67M

105.21%1.54M

24.61%1.13M

Current debt and capital lease obligation

-74.14%30K

-47.27%58K

-13.21%92K

16.50%120K

16.00%116K

254.84%110K

241.94%106K

232.26%103K

-Current capital lease obligation

-74.14%30K

-47.27%58K

-13.21%92K

16.50%120K

16.00%116K

--110K

--106K

--103K

Other current liabilities

--394K

5,436.84%1.05M

----

-86.23%19K

-83.24%57K

-86.34%115K

Current liabilities

12.86%4.6M

34.33%6.63M

1.29%5.09M

-43.75%4.84M

-57.11%4.08M

-51.87%4.94M

28.12%5.03M

162.82%8.61M

Non current liabilities

Long term debt and capital lease obligation

----

--0

-78.91%31K

--64K

--92K

--120K

-Long term capital lease obligation

----

--0

-78.91%31K

--64K

--92K

--120K

Derivative product liabilities

----

--1.05M

--1.54M

--2.93M

----

Total non current liabilities

--0

1,044.57%1.05M

1,181.67%1.54M

1,911.56%2.96M

--64K

--92K

--120K

Total liabilities

-34.59%4.6M

32.61%6.63M

20.05%6.14M

-26.91%6.38M

-27.12%7.03M

-51.24%5M

30.47%5.12M

166.48%8.73M

Shareholders'equity

Share capital

-94.74%2K

-94.12%2K

26.47%43K

31.25%42K

15.15%38K

-97.03%34K

-99.01%34K

-99.70%32K

-common stock

-97.30%1K

-96.97%1K

27.27%42K

32.26%41K

15.63%37K

-97.12%33K

-99.04%33K

-99.71%31K

-Preferred stock

0.00%1K

Retained earnings

-1.43%-684.33M

-1.13%-682.07M

-1.53%-679.1M

-2.22%-676.69M

-2.38%-674.7M

-3.20%-674.47M

-5.27%-668.88M

-5.09%-662M

Paid-in capital

0.28%689.64M

0.49%689.54M

0.62%689.07M

1.62%688.41M

1.62%687.71M

1.75%686.17M

3.13%684.8M

3.32%677.41M

Total stockholders'equity

-59.30%5.31M

-36.29%7.48M

-37.29%10.01M

-23.81%11.76M

-26.62%13.05M

-46.44%11.73M

-50.21%15.95M

-57.65%15.44M

Total equity

-59.30%5.31M

-36.29%7.48M

-37.29%10.01M

-23.81%11.76M

-26.62%13.05M

-46.44%11.73M

-49.95%15.95M

-57.46%15.44M

Currency Unit

USD

Audit Opinions

Unqualified Opinion

	(Q1)Mar 31, 2024	(FY)Dec 31, 2023	(Q4)Dec 31, 2023	(Q3)Sep 30, 2023	(Q2)Jun 30, 2023	(Q1)Mar 31, 2023	(FY)Dec 31, 2022	(Q4)Dec 31, 2022	(Q3)Sep 30, 2022	(Q2)Jun 30, 2022
Assets
Current assets
Cash, cash equivalents and short term investments	-50.72%9.81M	-15.36%13.97M	-15.36%13.97M	-22.95%16.01M	-24.24%17.97M	-25.58%19.9M	-48.38%16.51M	-48.38%16.51M	-41.80%20.78M	-39.94%23.73M
-Cash and cash equivalents	-4.65%1.95M	-80.98%1.08M	-80.98%1.08M	7.42%2.65M	-48.36%2.77M	-71.93%2.05M	-36.75%5.67M	-36.75%5.67M	-74.54%2.47M	-86.44%5.36M
-Short-term investments	-55.99%7.86M	18.98%12.89M	18.98%12.89M	-27.04%13.37M	-17.21%15.21M	-8.22%17.85M	-52.91%10.84M	-52.91%10.84M	-29.63%18.32M	--18.37M
Other current assets	105.26%78K	55.56%84K	55.56%84K	-56.82%38K	-78.38%48K	-91.61%38K	-71.58%54K	-71.58%54K	3.53%88K	258.06%222K
Total current assets	-50.42%9.89M	-15.13%14.06M	-15.13%14.06M	-23.09%16.05M	-24.75%18.02M	-26.68%19.94M	-48.52%16.56M	-48.52%16.56M	-41.70%20.87M	-39.48%23.95M
Non current assets
Net PPE	-80.71%27K	-67.88%53K	-67.88%53K	-54.21%87K	-46.73%114K	-40.93%140K	--165K	--165K	--190K	--214K
-Gross PPE	-80.71%27K	-67.88%53K	-67.88%53K	-54.21%87K	-46.73%114K	-40.93%140K	--165K	--165K	--190K	--214K
Non current prepaid assets	----	--0	--0	0.00%9K	0.00%9K	0.00%9K	--9K	--9K	--9K	--9K
Total non current assets	-81.88%27K	-69.54%53K	-69.54%53K	-51.76%96K	-44.84%123K	-39.43%149K	--174K	--174K	--199K	--223K
Total assets	-50.65%9.91M	-15.70%14.11M	-15.70%14.11M	-23.36%16.15M	-24.93%18.14M	-26.80%20.09M	-47.97%16.74M	-47.97%16.74M	-41.14%21.07M	-38.91%24.17M
Liabilities
Current liabilities
Payables	2.62%3.21M	37.83%4.33M	37.83%4.33M	19.40%3.97M	-51.80%3.5M	-61.41%3.13M	-61.66%3.14M	-61.66%3.14M	18.67%3.33M	385.17%7.26M
-accounts payable	2.62%3.21M	37.83%4.33M	37.83%4.33M	19.40%3.97M	-51.80%3.5M	-61.41%3.13M	-61.66%3.14M	-61.66%3.14M	18.67%3.33M	385.17%7.26M
Current accrued expenses	16.16%963K	-28.40%1.2M	-28.40%1.2M	-33.12%1.03M	8.24%1.22M	-29.15%829K	-12.20%1.67M	-12.20%1.67M	105.21%1.54M	24.61%1.13M
Current debt and capital lease obligation	-74.14%30K	-47.27%58K	-47.27%58K	-13.21%92K	16.50%120K	16.00%116K	254.84%110K	254.84%110K	241.94%106K	232.26%103K
-Current capital lease obligation	-74.14%30K	-47.27%58K	-47.27%58K	-13.21%92K	16.50%120K	16.00%116K	--110K	--110K	--106K	--103K
Other current liabilities	--394K	5,436.84%1.05M	5,436.84%1.05M	----	----	----	-86.23%19K	-86.23%19K	-83.24%57K	-86.34%115K
Current liabilities	12.86%4.6M	34.33%6.63M	34.33%6.63M	1.29%5.09M	-43.75%4.84M	-57.11%4.08M	-51.87%4.94M	-51.87%4.94M	28.12%5.03M	162.82%8.61M
Non current liabilities
Long term debt and capital lease obligation	----	--0	--0	--0	--0	-78.91%31K	--64K	--64K	--92K	--120K
-Long term capital lease obligation	----	--0	--0	--0	--0	-78.91%31K	--64K	--64K	--92K	--120K
Derivative product liabilities	----	----	----	--1.05M	--1.54M	--2.93M	----	----	----	----
Total non current liabilities	--0	--0	--0	1,044.57%1.05M	1,181.67%1.54M	1,911.56%2.96M	--64K	--64K	--92K	--120K
Total liabilities	-34.59%4.6M	32.61%6.63M	32.61%6.63M	20.05%6.14M	-26.91%6.38M	-27.12%7.03M	-51.24%5M	-51.24%5M	30.47%5.12M	166.48%8.73M
Shareholders'equity
Share capital	-94.74%2K	-94.12%2K	-94.12%2K	26.47%43K	31.25%42K	15.15%38K	-97.03%34K	-97.03%34K	-99.01%34K	-99.70%32K
-common stock	-97.30%1K	-96.97%1K	-96.97%1K	27.27%42K	32.26%41K	15.63%37K	-97.12%33K	-97.12%33K	-99.04%33K	-99.71%31K
-Preferred stock	0.00%1K	0.00%1K	0.00%1K	0.00%1K	0.00%1K	0.00%1K	0.00%1K	0.00%1K	0.00%1K	0.00%1K
Retained earnings	-1.43%-684.33M	-1.13%-682.07M	-1.13%-682.07M	-1.53%-679.1M	-2.22%-676.69M	-2.38%-674.7M	-3.20%-674.47M	-3.20%-674.47M	-5.27%-668.88M	-5.09%-662M
Paid-in capital	0.28%689.64M	0.49%689.54M	0.49%689.54M	0.62%689.07M	1.62%688.41M	1.62%687.71M	1.75%686.17M	1.75%686.17M	3.13%684.8M	3.32%677.41M
Total stockholders'equity	-59.30%5.31M	-36.29%7.48M	-36.29%7.48M	-37.29%10.01M	-23.81%11.76M	-26.62%13.05M	-46.44%11.73M	-46.44%11.73M	-50.21%15.95M	-57.65%15.44M
Total equity	-59.30%5.31M	-36.29%7.48M	-36.29%7.48M	-37.29%10.01M	-23.81%11.76M	-26.62%13.05M	-46.44%11.73M	-46.44%11.73M	-49.95%15.95M	-57.46%15.44M
Currency Unit	USD	USD	USD	USD	USD	USD	USD	USD	USD	USD
Audit Opinions	--	Unqualified Opinion	--	--	--	--	Unqualified Opinion	--	--	--

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List

Overall